We are now in crisis again because of Donald Trump’s executive order freezing aid. Surely local drug manufacture now needs to be implemented without any further delay?
FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls
A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. | The FDA ...
KODATEF is not approved for use in the U.S. Demand for ARAKODA has been steadily growing in recent months as awareness and use of the product has expanded across the U.S. The Company is taking the ...
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery ...
Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...
Explore the innovative world of 3D screen printing. Learn how this additive manufacturing technology from Axenoll and Exentis ...
Cosmos Health Inc. (NASDAQ:COSM) shares are trading slightly lower on Friday. The company revealed that its wholly owned subsidiary, Cana Laboratories, has entered into a ten-year contract ...
Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...
CHICAGO - Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group with a market capitalization of $15.18 million, has announced a new 10-year contract manufacturing agreement through its ...
Cosmos Health (COSM) announced that its wholly owned subsidiary, Cana Laboratories, has entered into a new long-term ten-year contract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback